Connacht Asset Management »

Cymabay Therapeutics shares owned by Connacht Asset Management

Quarter-by-quarter ownership of Cymabay Therapeutics shares owned by Connacht Asset Management from 13F filings

Historical chart of Connacht Asset Management investment in Cymabay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cymabay Therapeutics held by Connacht Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cymabay Therapeutics by Connacht Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $179k 12k 14.91
2023-06-30 $378k 35k 10.95
2023-03-31 $341k 39k 8.72